BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15232151)

  • 21. Cystic prostatic disease associated with adrenocortical lesions in the ferret (Mustela putorius furo).
    Coleman GD; Chavez MA; Williams BH
    Vet Pathol; 1998 Nov; 35(6):547-9. PubMed ID: 9823599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991).
    Rosenthal KL; Peterson ME; Quesenberry KE; Hillyer EV; Beeber NL; Moroff SD; Lothrop CD
    J Am Vet Med Assoc; 1993 Jul; 203(2):271-5. PubMed ID: 8407489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of immunomarkers for the identification of adrenocortical cells in cytology specimens.
    Jalali M; Krishnamurthy S
    Diagn Cytopathol; 2005 Aug; 33(2):78-82. PubMed ID: 16007649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
    Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
    Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous neoplasms of the ventral abdomen with features of adrenocortical tumors in two ferrets.
    Smith M; Schulman FY
    Vet Pathol; 2007 Nov; 44(6):951-5. PubMed ID: 18039913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteinizing Hormone and GATA4 Action in the Adrenocortical Tumorigenesis of Gonadectomized Female Mice.
    Doroszko M; Chrusciel M; Stelmaszewska J; Slezak T; Rivero-Muller A; Padzik A; Anisimowicz S; Wolczynski S; Huhtaniemi I; Toppari J; Rahman NA
    Cell Physiol Biochem; 2017; 43(3):1064-1076. PubMed ID: 28977799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
    Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.
    Beuschlein F; Looyenga BD; Bleasdale SE; Mutch C; Bavers DL; Parlow AF; Nilson JH; Hammer GD
    Mol Cell Biol; 2003 Jun; 23(11):3951-64. PubMed ID: 12748296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical aspects and surgical treatment of hyperadrenocorticism in the domestic ferret: 94 cases (1994-1996).
    Weiss CA; Scott MV
    J Am Anim Hosp Assoc; 1997; 33(6):487-93. PubMed ID: 9358415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncocytic adrenocortical carcinoma.
    Ohtake H; Kawamura H; Matsuzaki M; Yokoyama E; Kitajima M; Onizuka S; Yamakawa M
    Ann Diagn Pathol; 2010 Jun; 14(3):204-8. PubMed ID: 20471567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
    Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
    Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of transcription factors Ad4BP/SF-1 and DAX-1 as immunohistologic markers for diagnosis of advanced adrenocortical carcinoma.
    Kaneko T; Kojima Y; Umemoto Y; Sasaki S; Hayashi Y; Kohri K
    Horm Res; 2008; 70(5):294-9. PubMed ID: 18824868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex.
    Looyenga BD; Hammer GD
    Mol Endocrinol; 2006 Nov; 20(11):2848-63. PubMed ID: 16873442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadectomy-related adrenocortical tumors in ferrets demonstrate increased expression of androgen and estrogen synthesizing enzymes together with high inhibin expression.
    de Jong MK; ten Asbroek EE; Sleiderink AJ; Conley AJ; Mol JA; Schoemaker NJ
    Domest Anim Endocrinol; 2014 Jul; 48():42-7. PubMed ID: 24906927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adrenocortical tumors with neuroendocrine differentiation].
    Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
    Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenocortical carcinoma: review and update.
    Erickson LA; Rivera M; Zhang J
    Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncocytic adrenocortical carcinoma in a putty-nosed monkey (Cercopithecus nictitans) with hyperadrenocorticism.
    Gruber-Dujardin E; Jurczynski K; Kaup FJ; Mätz-Rensing K
    J Comp Pathol; 2013 Nov; 149(4):509-13. PubMed ID: 23746483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway.
    Anttonen M; Parviainen H; Kyrönlahti A; Bielinska M; Wilson DB; Ritvos O; Heikinheimo M
    J Mol Endocrinol; 2006 Jun; 36(3):557-68. PubMed ID: 16720723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.